Literature DB >> 4392560

Local anaesthetic and anti-arrhythmic actions of alprenolol relative to its effect on intracellular potentials and other properties of isolated cardiac muscle.

B N Singh, E M Williams.   

Abstract

1. Alprenolol, a beta-adrenoceptor blocking drug reported to have the same potency as propranolol in vitro and in vivo, was found to be four times more active than procaine as a local anaesthetic on frog sciatic nerve.2. At doses of 0.125 mg/kg and above alprenolol protected anaesthetized guinea-pigs against ouabain-induced ventricular fibrillation.3. In isolated rabbit atria, resting potentials were unchanged, and the duration of the action potential was not prolonged, by concentrations of alprenolol up to 10.5 x 10(-6)M. The maximum rate of depolarization (MRD), however, was reduced by 30% at a concentration of 0.525 x 10(-6)M. This was 214 times less than the concentration which reduced the frog action potential height by 25%.4. The concentration of alprenolol required to produce more than 15% decrease in contraction or maximum driven frequency was 3.5 x 10(-6)M.5. As a test of the direct action of alprenolol on isolated cardiac muscle, MRD was also a more sensitive test than the measurement of electrical threshold or conduction velocity.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4392560      PMCID: PMC1702589          DOI: 10.1111/j.1476-5381.1970.tb09884.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  16 in total

1.  Prevention of arrhythmias due to cardiac glycosides by block of sympathetic beta receptors.

Authors:  E M WILLIAMS; A SEKIYA
Journal:  Lancet       Date:  1963-02-23       Impact factor: 79.321

2.  The effect of subthreshold potentials on the membrane current in cardiac Purkinje fibres.

Authors:  R E McAllister; D Noble
Journal:  J Physiol       Date:  1967-05       Impact factor: 5.182

3.  Outward membrane currents activated in the plateau range of potentials in cardiac Purkinje fibres.

Authors:  D Noble; R W Tsien
Journal:  J Physiol       Date:  1969-01       Impact factor: 5.182

4.  Effect of tetrodotoxin on membrane currents in mammalian cardiac fibres.

Authors:  J Dudel; K Peper; R Rüdel; W Trautwein
Journal:  Nature       Date:  1967-01-21       Impact factor: 49.962

5.  The dependence of slow inward current in Purkinje fibres on the extracellular calcium-concentration.

Authors:  H Reuter
Journal:  J Physiol       Date:  1967-09       Impact factor: 5.182

6.  Pharmacological properties of H 56-28--a beta-adrenergic receptor antagonist.

Authors:  B Ablad; M Brogård; L Ek
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1967

7.  Hemodynamic effects of propranolol and H 56-28 in man--comparative study of two beta-adrenergic receptor antagonists.

Authors:  S A Forsberg; G Johnsson
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1967

8.  The mode of action of quinidine on isolated rabbit atria interpreted from intracellular potential records.

Authors:  E M VAUGHAN WILLIAMS
Journal:  Br J Pharmacol Chemother       Date:  1958-09

9.  The relevance of beta-receptor blockade to ouabain-induced cardiac arrhythmias.

Authors:  A N Dohadwalla; A S Freedberg; E M Vaughan Williams
Journal:  Br J Pharmacol       Date:  1969-06       Impact factor: 8.739

10.  The effect of sodium and calcium on the action potential of the smooth muscle of the guinea-pig taenia coli.

Authors:  A Brading; E Bülbring; T Tomita
Journal:  J Physiol       Date:  1969-02       Impact factor: 5.182

View more
  11 in total

1.  Antiarrhythmic drug research.

Authors:  M J A Walker
Journal:  Br J Pharmacol       Date:  2006-01       Impact factor: 8.739

2.  General concepts in the use of beta-blockers: the relative roles of specific and unspecific effects.

Authors:  H Brunner; P R Hedwall; M Meier
Journal:  Naunyn Schmiedebergs Arch Pharmakol       Date:  1971

3.  Atrial repolarization in man. Effect of beta-receptor blockade.

Authors:  S B Olsson
Journal:  Br Heart J       Date:  1974-08

4.  Inhibition of lymphocyte capping and transformation by propranolol and related compounds.

Authors:  B H Anderton; J S Axford; P Cohn; N J Marshall; L Shen; S Sprake
Journal:  Br J Pharmacol       Date:  1981-01       Impact factor: 8.739

5.  Measurement of hydrophobicity, surface activity, local anaesthesia, and myocardial conduction velocity as quantitative parameters of the non-specific membrane affinity of nine -adrenergic blocking agents.

Authors:  D Hellenbrecht; B Lemmer; G Wiethold; H Grobecker
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

Review 6.  Pharmacodynamic properties of beta-adrenergic receptor blocking drugs in man.

Authors:  D G Gibson
Journal:  Drugs       Date:  1974       Impact factor: 9.546

7.  The role of the local anaesthetic properties of beta-adrenoceptor blocking agents in antagonizing CaCl2-induced arrhythmias in the rat.

Authors:  S Evangelista; C A Maggi; A Meli
Journal:  Br J Pharmacol       Date:  1981-07       Impact factor: 8.739

8.  Effects on cardiac muscle of the -adrenoceptor blocking drugs INPEA and LB46 in relation to their local anaesthetic action on nerve.

Authors:  B N Singh; E M Williams
Journal:  Br J Pharmacol       Date:  1971-09       Impact factor: 8.739

9.  A third class of anti-arrhythmic action. Effects on atrial and ventricular intracellular potentials, and other pharmacological actions on cardiac muscle, of MJ 1999 and AH 3474.

Authors:  B N Singh; E M Vaughan Williams
Journal:  Br J Pharmacol       Date:  1970-08       Impact factor: 8.739

10.  Effect of phentolamine, alprenolol and prenylamine on maximum rate of rise of action potential in guinea-pig papillary muscles.

Authors:  H Sada
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-10       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.